KCTD7 antibody
Principal name
KCTD7 antibody
Alternative names for KCTD7 antibody
BTB/POZ domain-containing protein KCTD7
SwissProt ID
A4IFB4 (Bovin), B1WC97 (Rat), Q0VFV7 (Danre), Q5ZJP7 (Chick), Q8BJK1 (Mouse), Q96MP8 (Human)
Ncbi ID
9606, NP_694578, NM_001167961, NP_001161433, NP_001161433.1, NP_766097.1, NM_172509, NM_001128194, NM_153033
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB)
Background of KCTD7 antibody
- Kit Component:
- - KN308720G1, Kctd7 gRNA vector 1 in pCas-Guide vector
- KN308720G2, Kctd7 gRNA vector 2 in pCas-Guide vector
- KN308720D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Van (2007) Ann. Neurol. 61 (6), 579-586
Immunofluorescence of purified MaxPab antibody to KCTD7 on HeLa cell. [antibody concentration 10 ug/ml]
Western Blot analysis of KCTD7 expression in transfected 293T cell line (H00154881-T02) by KCTD7 MaxPab polyclonal antibody.Lane 1: KCTD7 transfected lysate(31.79 KDa).Lane 2: Non-transfected lysate.
Transfected 293T; WB Suggested Anti-KCTD7 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Transfected 293T; KCTD7 antibody - N-terminal region (ARP35422_P050) in Transfected 293T cells using Western Blot
Hum. Adult Placenta; Host: Rabbit. Target Name: KCTD7. Sample Tissue: Human Adult Placenta. Antibody Dilution: 1.0ug/ml.; KCTD7 antibody - N-terminal region (ARP35422_P050) in Hum. Adult Placenta cells using Western Blot
Hum. Fetal Heart; Host: Rabbit. Target Name: KCTD7. Sample Tissue: Human Fetal Heart. Antibody Dilution: 1.0ug/ml.; KCTD7 antibody - N-terminal region (ARP35422_P050) in Hum. Fetal Heart cells using Western Blot
Hum. Fetal Lung; Host: Rabbit. Target Name: KCTD7. Sample Tissue: Human Fetal Lung. Antibody Dilution: 1.0ug/ml.; KCTD7 antibody - N-terminal region (ARP35422_P050) in Hum. Fetal Lung cells using Western Blot
WB Suggested Anti-KCTD7 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: Transfected 293T
Host: Rabbit; Target Name: KCTD7; Sample Tissue: Human Adult Placenta; Antibody Dilution: 1.0 ug/ml
Host: Rabbit; Target Name: KCTD7; Sample Tissue: Human Fetal Lung; Antibody Dilution: 1.0 ug/ml
Host: Rabbit; Target Name: KCTD7; Sample Tissue: Human Fetal Heart; Antibody Dilution: 1.0 ug/ml
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP329837 | KCTD7 (transcript variant 2) |
||||
| Recombinant protein of human potassium channel tetramerisation domain containing 7 (KCTD7), transcript variant 2. | |||||
 |
Human | > 80 % Preparation: or Add: Recombint proteins was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP760892 | KCTD7 (full length, N-term HIS tag, transcript variant 1) |
||||
| Purified recombinant protein of Human potassium channel tetramerisation domain containing 7 (KCTD7), transcript variant 1, full length, with N-terminal HIS tag, expressed in E. coli, 50ug | |||||
 |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY432837 | KCTD7 overexpression lysate |
|
 |
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR206071L2V | Lenti ORF particles, Kctd7 (GFP-tagged ORF) - Rat potassium channel tetramerisation domain containing 7 (Kctd7), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR206071L1V | Lenti ORF particles, Kctd7 (Myc-DDK-tagged ORF) - Rat potassium channel tetramerisation domain containing 7 (Kctd7), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
